| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial
|
Schmidt, Marcus
|
|
|
194 |
C |
p.
|
artikel
|
| 2 |
Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges
|
Zappa, Elisa
|
|
|
194 |
C |
p.
|
artikel
|
| 3 |
At the right dose: personalised (N-of-1) dosing for precision oncology
|
Nikanjam, Mina
|
|
|
194 |
C |
p.
|
artikel
|
| 4 |
Clinical and genomic characterisation of early-onset pancreatic cancer
|
Castet, Florian
|
|
|
194 |
C |
p.
|
artikel
|
| 5 |
Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: based on science or just revenues?
|
Ratain, Mark J.
|
|
|
194 |
C |
p.
|
artikel
|
| 6 |
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
|
Mehta, Ishan
|
|
|
194 |
C |
p.
|
artikel
|
| 7 |
Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” Eur J Cancer. 2023 Jan;178:162–170
|
Margalit, Ofer
|
|
|
194 |
C |
p.
|
artikel
|
| 8 |
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study
|
Muti, Hannah S.
|
|
|
194 |
C |
p.
|
artikel
|
| 9 |
Does perioperative immunotherapy reduce the risk of second primary cancers?
|
Tagliamento, Marco
|
|
|
194 |
C |
p.
|
artikel
|
| 10 |
Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour
|
Klein, Oliver
|
|
|
194 |
C |
p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
194 |
C |
p.
|
artikel
|
| 12 |
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer
|
Fox, Daniel A.
|
|
|
194 |
C |
p.
|
artikel
|
| 13 |
European trends in ovarian cancer mortality, 1990–2020 and predictions to 2025
|
Wojtyła, Cezary
|
|
|
194 |
C |
p.
|
artikel
|
| 14 |
Gender inequity in cancer research leadership in Europe: Time to act
|
Lawler, Mark
|
|
|
194 |
C |
p.
|
artikel
|
| 15 |
Immune checkpoint inhibitors-associated myocarditis without cardiovascular symptoms
|
Abitbol, Jonathan
|
|
|
194 |
C |
p.
|
artikel
|
| 16 |
Immune effector cell-associated acute stroke: A novel entity?
|
Mauget, Matteo
|
|
|
194 |
C |
p.
|
artikel
|
| 17 |
Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis
|
Martins-Branco, Diogo
|
|
|
194 |
C |
p.
|
artikel
|
| 18 |
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma
|
Goodman, Rachel S.
|
|
|
194 |
C |
p.
|
artikel
|
| 19 |
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
|
Le Tourneau, Christophe
|
|
|
194 |
C |
p.
|
artikel
|
| 20 |
Myoepithelial carcinoma of soft tissues and bone
|
Aiba, Hisaki
|
|
|
194 |
C |
p.
|
artikel
|
| 21 |
Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)
|
Overbeek, Joanneke K.
|
|
|
194 |
C |
p.
|
artikel
|
| 22 |
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
|
Sherry, Alexander D.
|
|
|
194 |
C |
p.
|
artikel
|
| 23 |
Re: A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases
|
Ding, Silu
|
|
|
194 |
C |
p.
|
artikel
|
| 24 |
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
|
Guo, Shan-Shan
|
|
|
194 |
C |
p.
|
artikel
|
| 25 |
Response to programmed cell death protein 1 antibody in patients with Epstein–Barr virus-associated intrahepatic cholangiocarcinoma
|
He, Wen-Zhuo
|
|
|
194 |
C |
p.
|
artikel
|
| 26 |
The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy
|
Tan, Xingliang
|
|
|
194 |
C |
p.
|
artikel
|
| 27 |
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer
|
Rasola, Cosimo
|
|
|
194 |
C |
p.
|
artikel
|
Tijdschrift beschrijving